Depression During Pregnancy and Postpartum.
Publication/Presentation Date
3-1-2016
Abstract
Depression is a common complication of pregnancy and the postpartum period. There are multiple risk factors for peripartum mood disorders, most important of which is a prior history of depression. Both depression and antidepressant medications confer risk upon the infant. Maternal depression has been associated with preterm birth, low birth weight, fetal growth restriction, and postnatal cognitive and emotional complications. Antidepressant exposure has been associated with preterm birth, reductions in birth weight, persistent pulmonary hypertension, and postnatal adaptation syndrome (PNAS) as well as a possible connection with autism spectrum disorder. Paroxetine has been associated with cardiac malformations. Most antidepressant medications are excreted in low levels in breast milk and are generally compatible with breastfeeding. The use of antidepressants during pregnancy and postpartum must be weighed against the risk of untreated depression in the mother.
Volume
18
Issue
3
First Page
32
Last Page
32
ISSN
1535-1645
Published In/Presented At
Becker, M., Weinberger, T., Chandy, A., & Schmukler, S. (2016). Depression During Pregnancy and Postpartum. Current psychiatry reports, 18(3), 32. https://doi.org/10.1007/s11920-016-0664-7
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
26879925
Department(s)
Administration and Leadership
Document Type
Article